Around 30% of hereditary breast cancer cases result from mutations of rare but highly penetrant genes, including BRCA1, BRCA2, PTEN, TP53, CDH1, and STK11, which account for approximately 80% of breast cancer risk. This evidence concerns the gene PTEN and breast carcinoma.